🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Several professionals stated the popularity for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

According to the social media company, the platform has taken down violative material and banned related hashtags and search suggestions. The company said it was committed to maintaining the service secure and investing in enhancing compliance measures.

Digital Trading Activities

Investigations also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of weight loss, positive reviews and detailed instructions for preparing or injecting at home.

Within minutes of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Information and Costs

Inside these groups, messages display dark colored packages with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram stated it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering materials they can’t verify. Although the science behind this drug is sound, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has previously encountered patients injured by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to potentially significant medical dangers”.